Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Iteris Sets Fiscal Fourth Quarter and Full Year 2024 Conference Call for Thursday, June 13, 2024 at 4:30 p.m. ET


Iteris, Inc. (NASDAQ: ITI), the world's trusted technology ecosystem for smart mobility infrastructure management, today announced that it will conduct a conference call on Thursday, June 13th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal fourth quarter and full year ended March 31, 2024. The financial results will be issued in a press release prior to the call.

Iteris president and CEO Joe Bergera and CFO Kerry Shiba will host the call, followed by a question and answer period.

Date: Thursday, June 13, 2024
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Toll-free dial-in number: +1 888-506-0062
International dial-in number: +1 973-528-0011
Participant Access Code: 321295

If joining by phone, please call the conference telephone number 5-10 minutes prior to the start time and ask to join the Iteris earnings call. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MKR Investor Relations at 1-213-277-5550.

To listen to the live webcast or view the press release, please visit the investor relations section of the Iteris website at www.iteris.com.

During the question and answer period, management will take questions live from covering sell-side analysts, as well as answer select questions submitted to the company in advance of the call. If you would like to submit a question in advance, please do so before 5 p.m. Eastern time (2 p.m. Pacific time) on June 12, 2024 by emailing Iteris investor relations at [email protected].

A telephone replay of the conference call will be available approximately two hours following the end of the call and will remain available for one week. To access the replay dial +1 877-481-4010 (US and Canada Toll Free) or +1 919-882-2331 (International) and enter replay passcode 50705.

About Iteris, Inc.

Iteris is the world's trusted technology ecosystem for smart mobility infrastructure management. Delivered through Iteris' ClearMobility® Platform, our AI-powered end-to-end solutions monitor, visualize and optimize mobility infrastructure around the world and help bridge legacy technology silos to unlock the future of transportation. That's why more than 10,000 public agencies and private-sector enterprises focused on mobility rely on Iteris every day. Visit www.iteris.com for more information, and join the conversation on Twitter, LinkedIn and Facebook.


These press releases may also interest you

at 21:00
Coway, the "Best Life Solution Company," announced today that its Seoul-based R&D Center, the Environmental Technology Research Institute, has been...

at 20:46
It is a vision of a new era of intelligent and integrated school-home communication solutions powered by AI.Over the last year, Bloomz worked with many customers big and small and we have heard common themes....

at 20:45
Cinedapt®, an innovator in film technology, is thrilled to announce the public waitlist for its patented, award-winning, copyright-respecting Artificial Intelligence technology. With a focus on respecting copyrights and fostering job growth in the...

at 20:05
China Hi-Tech Fair (CHTF), a large-scale international event and China's premier tech show showcasing innovative technologies and products, will kick off its 26th edition on November 14-16, 2024 at Shenzhen World Exhibition & Convention Center under...

at 20:00
Exro Technologies Inc. (the "Company" or "Exro"), a leading clean technology company that provides proprietary motor-control and complete electric propulsion system technology for e-mobility, today announced interest payment details in relation to...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...



News published on and distributed by: